Experimental Agent Offers First Hope for Rare Genetic Disorder Experimental Agent Offers First Hope for Rare Genetic Disorder

An experimental agent promises to improve the lives of patients with Angelman syndrome, a rare genetic disorder for which there are no approved therapies and that carries a high, unmet medical need.Medscape Medical News
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news